Aytu BioPharma Inc. (AYTU)
NASDAQ · Healthcare
Aytu BioPharma Inc. Gross Profit 2014–2025
Aytu BioPharma Inc. annual/quarterly gross profit history and growth rate from 2015 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Aytu BioPharma Inc. gross profit for the quarter ending March 31, 2026 was 7.6 M, a 40.66% decrease year-over-year.
- Aytu BioPharma Inc. gross profit for the twelve months ending March 31, 2026 was 39.2 M, a 17.85% decrease year-over-year.
- Aytu BioPharma Inc. annual gross profit for 2025 was 45.8 M, a 6.57% decrease from 2024.
- Aytu BioPharma Inc. annual gross profit for 2024 was 49.1 M, a 26.38% decrease from 2023.
- Aytu BioPharma Inc. annual gross profit for 2023 was 66.6 M, a 27.44% increase from 2022.
- Aytu BioPharma Inc. annual gross profit for 2022 was 52.3 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aytu BioPharma Inc. Gross Profit — FAQ
Aytu BioPharma Inc. (AYTU) gross profit over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
What is Aytu BioPharma Inc.'s gross profit?
Aytu BioPharma Inc. (AYTU) reported gross profit of $46M for fiscal 2025.
Where can I see AYTU's gross profit history?
The chart and table above show Aytu BioPharma Inc.'s gross profit by year and by quarter, including the growth rate.